Menu Search
Equities

Advanced Medical Solutions Group PLC

AQA:STU

Advanced Medical Solutions Group PLC

Actions
  • Price (EUR)2.08
  • Today's Change0.02 / 0.97%
  • Shares traded0.00
  • 1 Year change-22.96%
  • Beta--
Data delayed at least 15 minutes, as of Apr 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Advanced Medical Solutions Group plc is a United Kingdom-based company that specializes in the design, development, manufacture and distribution of novel tissue-healing technologies, including advanced wound care products, surgical dressings and medical grade materials, as well as medical adhesives and sutures for closing and sealing tissue. The Company manufactures a range of products and materials that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats. It operates through two divisions for its sales, marketing and research and development (R&D) activities, including Surgical and Woundcare. Its surgical business unit is focused on selling and marketing its branded products and are sold directly and through distributors. Its Woundcare business unit is focused on distribution and marketing its products that are supplied to medical device partners under their own brands. The Company offers its products under ActivHeal, LiquiBand and RESORBA.

  • Revenue in GBP (TTM)126.21m
  • Net income in GBP15.89m
  • Incorporated1993
  • Employees800.00
  • Location
    Advanced Medical Solutions Group PLCPremier Park, 33 Road OneWINSFORD CW7 3RTUnited KingdomGBR
  • Phone+44 160 686 3500
  • Fax+44 160 686 3600
  • Websitehttps://www.admedsol.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.